https://ift.tt/2IVHF6y

Aurobindo Pharma was up 9% at Rs 826, surging 22% in past three trading days after the company on Thursday announced the acquisition of Sandoz's generic business in the US for $900 million.

from Markets https://ift.tt/2NSDGGl

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads